Skip to main content
  • Notice of Privacy Incident
  • Medicaid Provider Termination Alert: Revalidation deadlines are approaching. Failure by providers to revalidate will lead to termination and payment suspension. Check your account now at https://impact.illinois.gov/ to learn if your required revalidation is due this month. More revalidation information here.
Elizabeth M. Whitehorn, Director

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: September 17, 2014

Drug Name Review Type Class Manufacturer
Otezla New Drug Initial Review Phosphodiesterase 4 Inhibitor Celgene
Hemangeol New Drug Initial Review Beta-Adrenergic Blocker Pierre Fabre
Opsumit New Drug Initial Review Pulmonary Aterial Hypertension Actelion
Orenitram ER New Drug Initial Review Pulmonary Aterial Hypertension United Therapeutics
Mycamine New Drug Initial Review Anti-fungal Astellas
Ambisome New Drug Initial Review Anti-fungal Astellas
Brilinta PDL Appeal Platelet Aggregation Inhibitor Astra Zeneca